Abstract
Objective:
This study examines whether overweight in midlife increases dementia risk later in life.
Methods:
In 1963 body mass index was assessed in 1152 participants of The Swedish Twin Registry, at the age of 45–65 years. These participants were later screened for dementia in a prospective study with up to 40 years follow-up. A total of 312 participants were diagnosed with dementia.
Results:
Logistic regression analyses adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR=1.59; 95% CI: 1.21–2.07, P=0.002), Alzheimer's disease (OR=1.71; 95% CI: 1.24–2.35, P=0.003), and vascular dementia (OR=1.55; 95% CI: 0.98–2.47, P=0.059). Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR=1.36; 95% CI: 0.82–2.56, P=0.116), reflecting the significance of diabetes and vascular diseases in the etiology of vascular dementia. There was no significant interaction between overweight and APOE ɛ4 status, indicating that having both risk factors does not have a multiplicative effect with regard to dementia risk.
Conclusions:
This study gives further support to the notion that overweight in midlife increases later risk of dementia. The risk is increased for both Alzheimer's disease and vascular dementia, and follows the same pattern for men and women.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524–1528.
Rosengren A, Skoog I, Gustafson D, Wilhelmsen L . Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005; 165: 321–326.
Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry Jr CP, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360.
Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K . Central obesity and increased risk of dementia more than three decades later. Neurology 2008; 71: 1057–1064.
Dahl A, Hassing LB, Fransson E, Berg S, Gatz M, Reynolds CA et al. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J Gerontol: Med Sci 2009; doi: 10.1093/gerona/glp035.
Beydoun MA, Lhotsky A, Wang Y, Dal Forno G, An Y, Metter EJ et al. Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. Am J Epidemiol 2008; 168: 1179–1189.
Beydoun MA, Beydoun HA, Wang Y . Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204–218.
Gorospe EC, Dave JK . The risk of dementia with increased body mass index. Age Ageing 2007; 36: 23–29.
Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005; 62: 55–60.
White H, Pieper C, Schmader K . The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc 1998; 46: 1223–1227.
Baumgartner RN, Heymsfield SB, Roche AF . Human body composition and the epidemiology of chronic disease. Obes Res 1995; 3: 73–95.
Gustafson D . Adiposity indices and dementia. Lancet Neurol 2006; 5: 713–720.
Launer LJ . The epidemiologic study of dementia: a life-long quest? Neurobiol Aging 2005; 26: 335–340.
Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006; 20: 93–100.
Whitmer RA, Gunderson EP, Quesenberry Jr CP, Zhou J, Yaffe K . Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 2007; 4: 103–109.
Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL . The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 2002; 252: 184–205.
Lichtenstein P, Sullivan PF, Cnattingius S, Gatz M, Johansson S, Carlström E et al. The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet 2006; 9: 875–882.
Pedersen NL, McClearn GE, Plomin R, Nesselroade JR, Berg S, DeFaire U . The Swedish Adoption Twin Study of Aging: an update. Acta Genet Med Gemellol (Roma) 1991; 40: 7–20.
McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997; 276: 1560–1563.
Stunkard AJ, Harris JR, Pedersen NL, McClearn GE . The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483–1487.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn.-rev. American Psychiatric Association: Washington, DC, 1987.
Pedersen NL, Gatz M, Berg S, Johansson B . How heritable is Alzheimer's disease late in life? Findings from Swedish twins. Ann Neurol 2004; 55: 180–185.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–260.
Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991; 41: 1886–1892.
Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992; 42: 115–119.
Raudenbush SW, Bryk AS . Hierarchical Linear Models: Application and Data Analysis Methods, 2nd edn. Sage Publications: London, 2002.
SAS 9.1. In. Version 9.1 ed. Cary, NC: SAS Institute Inc.; 2002–2003:Computer program.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923.
Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649–9653.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556–1560.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327–334.
Bruun JM, Pedersen SB, Kristensen K, Richelsen B . Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 2002; 190: 91–99.
Trayhurn P, Wood IS . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347–355.
Yaffe K . Metabolic syndrome and cognitive decline. Curr Alzheimer Res 2007; 4: 123–126.
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383–421.
Acknowledgements
This study is supported by a grant from The Bank of Sweden Tercentenary Foundation and by grants from NIA (AG04563, AG08724, AG08861, AG10175). Data for the analyses were drawn from two Swedish twin studies of aging, the OCTO-Twin and SATSA supported by grants from NIA (AG04563, AG08724, AG08861, AG10175). None of the funding organizations had a role in design or conduct of the study; collection, management, analysis or interpretation of the data; or preparation, review or approval of the article. Dr Hassing had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analyses. The study concept and design was done by Hassing, Dahl, Gatz, Pedersen and Johansson. Berg, Gatz, Pedersen and Johansson were responsible for the acquisition of data. Hassing, Dahl, Thorvaldsson, Gatz and Johansson were responsible for the analysis and interpretation of data. Hassing drafted the article. Hassing, Dahl, Thorvaldsson, Berg, Gatz, Pedersen and Johansson were responsible for the critical revision of the article for important intellectual content. Hassing, Pedersen and Thorvaldsson was responsible for the statistical analyses. Hassing, Berg, Gatz, Pedersen and Johansson obtained funding. Administrative, technical and material support was given by Berg and Gatz. Study supervision was done by Gatz and Johansson.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hassing, L., Dahl, A., Thorvaldsson, V. et al. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes 33, 893–898 (2009). https://doi.org/10.1038/ijo.2009.104
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2009.104
Keywords
This article is cited by
-
Associations of truncal body composition with cognitive status in patients with dementia
Neurological Sciences (2021)
-
Targeting Insulin Resistance to Treat Cognitive Dysfunction
Molecular Neurobiology (2021)
-
Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge
Journal of Neuroinflammation (2020)
-
Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice
Acta Pharmacologica Sinica (2020)
-
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Signal Transduction and Targeted Therapy (2019)